Operator

Good morning, ladies and gentlemen, and a warm welcome to today's earnings call of the Carl Zeiss Meditec Group following the publication of the 6-month figures of 2025/2026. And with this, I hand over to the Head of Group Finance and Investor Relations, Sebastian Frericks.

Sebastian Frericks
Director of Investor Relations

Hello. Good morning, everybody, and thank you for joining our 6 months '25/'26 earnings call. As usual, our management will guide you through our financials, and then we will talk quite a bit today about our ProfitUp program, including the cost restructuring and portfolio measures that we are planning as well as give you a new outlook for the current fiscal year '25/'26 and an update on our midterm targets. With that, I'll hand it over to Andreas Pecher, our CEO. And then afterwards, Justus, our CFO, will take the financial question.

Andreas Pecher
Interim Chairman of the Management Board & Interim CEO

Great. Thank you, Sebastian. Well, good morning to analysts and to investors. Well, welcome to the 6 months '25/'26 of Carl Zeiss Meditec AG. Justus and I will walk you through the quarterly overview and financial results. After that, we'll dive deeper and share more details about our ProfitUp program. And at the end, we'll present our guidance for fiscal year '25/'26 and